Evidence map›Paper›PMID 23844936›Full record

ArticleMolecular oral microbiology2013

Perturbation of the indigenous rat oral microbiome by ciprofloxacin dosing.

P Manrique, M O Freire, C Chen, H H Zadeh, M Young, P Suci

Abstract read
In one paragraph

Article in Molecular oral microbiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Comparative genomics ofMicrobial genomics · 2022
    Article
  3. Review
  4. Article
  5. Article
  6. A Uniquely Altered Oral Microbiome Composition Was Observed in Pregnant Rats WithFrontiers in cellular and infection microbiology · 2020
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

P ManriqueDepartment of Microbiology, Montana State University, Bozeman, MT 59717, USA.
M O Freire
C Chen
H H Zadeh
M Young
P Suci

Funding

Novel clone-specific virulence determinants of A. actinomycetemcomitansR01DE012212 · NIDCR · UNIVERSITY OF SOUTHERN CALIFORNIA · PI CHEN, CASEY · 1999 to 2016
$5.0M
Small molecular weight targeted killing agents against a periodontal pathogenR21DE022882 · NIDCR · MONTANA STATE UNIVERSITY - BOZEMAN · PI YOUNG, MARK J · 2013 to 2014
$396k
Targeted combinatiorial therapy for treatment of periodontal diseaseR21DE019237 · NIDCR · MONTANA STATE UNIVERSITY - BOZEMAN · PI YOUNG, MARK J · 2009 to 2010
$392k
NIDCR NIH HHS 1R21DE019237-01A1NIDCR NIH HHS R01 DE012212NIDCR NIH HHS R21 DE019237NIDCR NIH HHS R21 DE022882
6 · The paper itself

Abstract

Mucosal surfaces such as the gut, vagina and oral cavity are colonized by microbiota that are an integral component of the healthy ecosystem. Recent molecular techniques make it feasible to correlate antimicrobial dosing levels with changes in microbiome composition. The objective of this study was to characterize the rat oral plaque microbiome composition at doses of ciprofloxacin that were considerably above and below nominal in vitro minimal inhibitory concentrations of a variety of gram-positive oral commensal bacteria. We exposed the oral cavities of rats to relatively low (0.1 μg ml(-1) ) and high (20 μg ml(-1)) doses of ciprofloxacin in the drinking water over a 3-day period. Plaque microbiota were characterized using 454 pyrosequencing. The rat indigenous community was dominated by the genera Rothia (74.4%) and Streptococcus (4.7%). Dosing at 0.1 μg ml(-1) was associated with changes in Rothia and Streptococcus species that were not significant, whereas dosing at 20 μg ml(-1) caused a pronounced (significant) reduction in the relative abundance of the Streptococcus genus. Taxonomic independent analysis indicated that the perturbation in the overall community structure attributed to dosing with ciprofloxacin at either the low or high dose was relatively low. The results suggest that it is feasible to use an antimicrobial dosing regimen to selectively target a specific subset of a mucosal microbiome for elimination with minimal perturbation of the entire community.

Indexed as

ActinomycetaceaeAnimalsAnti-Bacterial AgentsBacterial LoadCiprofloxacinDental PlaqueFeasibility StudiesFemaleGram-Positive BacteriaMicrobial ConsortiaMicrobial Sensitivity TestsMicrobiotaMouthRatsRats, Sprague-DawleyRNA, BacterialAnti-Bacterial AgentsCiprofloxacinRNA, BacterialRNA, Ribosomal, 16Sciprofloxacinmicrobiomeoralperiodontitisrat

Identifiers

PMID23844936
PMCPMC3767763

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.